Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
JSPR
Stock Latest News
The Fly
Jasper Therapeutics price target lowered to $65 from $80 at Oppenheimer
11d ago
JSPR
Premium
The Fly
Jasper Therapeutics price target lowered to $33 from $38 at UBS
13d ago
JSPR
Premium
Ratings
Promising Advancements in Jasper Therapeutics’ Briquilimab Programs Highlight Market Potential
13d ago
JSPR
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Promising Clinical Developments and Strategic Updates Support Buy Rating
13d ago
JSPR
Premium
Company Announcements
Jasper Therapeutics Faces Financial Challenges Amid Rising R&D Costs
13d ago
JSPR
Premium
The Fly
Jasper Therapeutics reports Q1 EPS ($1.41), consensus ($1.48)
13d ago
JSPR
Premium
Pre-Earnings
JSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
JSPR
Premium
Company Announcements
Jasper Therapeutics Signs New Sales Agreement with Jefferies
2M ago
8K
JSPR
Premium
The Fly
Jasper Therapeutics files $300M mixed securities shelf
2M ago
JSPR
Premium
Ratings
Promising Innovations in Chronic Urticaria Treatment Drive Buy Rating for Jasper Therapeutics
3M ago
JSPR
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Buy Rating Affirmed on Promising BEACON Study Data and Strategic Milestones
3M ago
JSPR
Premium
Ratings
Positive Outlook on Jasper Therapeutics: Sustained Efficacy and Safety of Briquilimab in CSU Treatment
3M ago
JSPR
Premium
Ratings
Promising Outlook for Jasper Therapeutics: Buy Rating Amidst Potential Upside and Strategic Developments
3M ago
JSPR
Premium
The Fly
Jasper Therapeutics presents updated data from Phase 1b/2a BEACON study
3M ago
JSPR
Premium
Ratings
Buy Recommendation for Jasper Therapeutics: Promising Developments in Briquilimab’s Phase 2b Program
3M ago
JSPR
Premium
Ratings
Promising Outlook for Jasper Therapeutics: Buy Rating Backed by Briquilimab’s Clinical Progress and Financial Stability
3M ago
JSPR
Premium
Company Announcements
Jasper Therapeutics Reports Promising Clinical Progress
3M ago
JSPR
Premium
Ratings
Jasper Therapeutics: Strategic Advancements and Promising Clinical Efficacy Drive Buy Rating
3M ago
JSPR
Premium
Ratings
Promising Data from Jasper Therapeutics’ BEACON and SPOTLIGHT Studies Justify Buy Rating for Briquilimab
3M ago
JSPR
Premium
The Fly
Jasper Therapeutics reports Q4 EPS ($1.62), consensus ($1.23)
3M ago
JSPR
Premium
The Fly
Jasper Therapeutics initiated with a Buy at UBS
3M ago
JSPR
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
TM
ALT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
